Close Navigation
About ArixStrategy
OverviewInvestment CaseNewsResultsDocumentsEventsCalendarAnalystsStock infoContactTransactionTransaction Details
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
OverlayOverlay
Artios logo

Find out more →

OverlayOverlay
Aura logo

Find out more →

OverlayOverlay
OverlayOverlay
OverlayOverlay

INVESTING IN LIFE CHANGING SCIENCE

Discover more

Our Portfolio

With a focus on late pre-clinical to clinical stage ventures and covering a diversified range of therapeutic areas, we partner with the most ambitious scientists and entrepreneurs to build companies around game-changing life science innovation.

View full portfolio
Video
Video

Team

Experienced and collaborative team, with deep industry and scientific expertise.

Meet the team

Tom Davidson

Finance Director

Tassos Konstantinou, PhD

Managing Director

Jade Fletcher

Financial Controller

Roy Bartel-Taverner, MD

Analyst

Robert Lyne

CEO

Laura Craig

Investor Relations Officer

Felix Breyer, PhD

Associate

Mesh

Investors

Public market access to revolutionary medical innovation

Find the latest share price, presentations, events and regulatory announcements here

Visit Investor Centre
Share price

Latest News

Updates from Arix and our porfolio companies.

Read more news

Arix

8th December 2023

Portfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial

Portfolio Company

7th December 2023

Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma

Portfolio Company

14th November 2023

Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin

Portfolio Company

9th November 2023

Enliven Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

Arix Bioscience

About Arix

The Team

Portfolio

Insights

News & Events

Contact

Investor Relations

Results Centre

Financial Calendar

Regulatory News

Document Library

Analysts & Advisors

Shareholder Information

Meta

Privacy Policy

Terms of use

Cookie Policy

Stay up to date

Sign up to receive regulatory news and results

Subscribe
Arix Bioscience
linkedintwitter

Arix Bioscience plc, registered in England and Wales with company number 09777975

Registered office: Duke Street House, 50 Duke Street, London, W1K 6JL, United Kingdom

Website by Ether